Prospective Study To Assess The Safety And Effectiveness Of Tixel Treatment On Dry Eye Symptoms In Asian Patients
NCT04260893 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2021-05-07
Summary
Pilot study where effect of standard Tixel treatment as used for periorbital wrinkles would be assessed on Dry Eye Disease symptoms and signs in Asian Patients.
Conditions
- Dry Eye Syndromes
- Dry Eye
Interventions
- DEVICE
-
Tixel
Peri-Orbital fractional treatment on the Eye-Lid to assess the effect on Dry Eye symptoms
Sponsors & Collaborators
-
Novoxel Ltd.
lead INDUSTRY
Principal Investigators
-
Sunil Shah, MD · University of Puthasastra
-
Mukesh Taneja, MD · University of Puthasastra
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-23
- Primary Completion
- 2021-03-13
- Completion
- 2021-03-13
Countries
- Cambodia
Study Locations
More Related Trials
-
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy Study
NCT04884217 ·Status: UNKNOWN ·Phase: PHASE2
-
to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
NCT05162261 ·Status: COMPLETED ·Phase: NA
-
Assessing Safety and Efficacy of DE-089 Ophthalmic Solution in Patients With Dry Eye Disease
NCT03216096 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01240382 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
NCT05618730 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
NCT02254265 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
NCT04030962 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
NCT00600288 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
NCT05245604 ·Status: UNKNOWN ·Phase: PHASE3
-
LME636 in the Relief of Persistent Ocular Discomfort in Subjects With Severe Dry Eye Disease
NCT02365519 ·Status: COMPLETED ·Phase: PHASE2
-
Viveye Ocular Magnetic Neurostimulation System (OMNS) for the Management of Severe Dry Eye Disease
NCT04143841 ·Status: TERMINATED ·Phase: NA
-
Study of Application of Pulse Electrical Stimulation Around Eye in Dry Eye Disease Patients Who Are Scheduled for Laser Epithelial Keratomileusis (LASEK) Surgery
NCT06120348 ·Status: RECRUITING ·Phase: NA
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparing Efficacy and Safety of TJO-083 in Dry Eye Disease Patients
NCT05346783 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease
NCT05841043 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Lifitegrast 5% on Tear Film Markers
NCT03952481 ·Status: WITHDRAWN ·Phase: PHASE4
-
Punctal Plugs and Iodine Related Discomfort
NCT03396809 ·Status: WITHDRAWN ·Phase: NA
-
Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye
NCT02965846 ·Status: TERMINATED ·Phase: PHASE3
-
A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.
NCT06780306 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens
NCT01061268 ·Status: COMPLETED ·Phase: PHASE4